Key result
Chronic coronary occlusion in a canine model induced upregulation of MMPs and decreased TIMP-1 levels in collateral vessels compared with normal LAD vessels.
Why the study?
Does chronic coronary occlusion alter the expression of extracellular matrix metalloproteinases and tissue plasminogen activator in collateral vessels in a canine model?
Does chronic coronary occlusion alter the expression of extracellular matrix metalloproteinases and tissue plasminogen activator in collateral vessels in a canine model?
Chronic coronary occlusion induces upregulation of vascular remodeling mechanisms, including increased MMP activity and decreased TIMP-1, subserving collateral development.
Answers are grounded in this paper and cite their sources.
Suggests MMP/TIMP imbalance as a collateral remodeling target; leaves open translation to human CAD.
Although heart attack is caused by occlusion of a major coronary artery, some patients have occlusion without heart attack because these patients have sufficient collateral circulation to provide an alternate pathway for blood supply to the myocardium at ischemic risk. The growth of new capillary vessels (angiogenesis) and enlargement of preexisting vessels play an important role in the collateral development. We evaluated the hypothesis that extracellular matrix metalloproteinase (MMP) expression is altered in coronary collateral arteries (0.5-1 mm o.d.) isolated from canine hearts 2-4 months after surgical placement of an ameroid occluder around the proximal left circumflex artery (n = 4), during the development of collateral vessels and restructuring new vessels. Histologic studies (hematoxylin and eosin, trichrome, and van Gieson stains) indicated cellular proliferation and increased collagen and elastin content in collateral vessels compared with comparable-sized unoccluded arterial segments of the left anterior descending (LAD) artery. In situ MMP activity of collateral vessels, measured using denatured collagen in the gel matrix, indicated an increase in total MMP activity in the intima of collateral vessels compared with normal LAD vessels. To further identify the type of MMP, tissue homogenates were prepared from collateral and LAD vessels and analyzed by SDS-PAGE zymography. The results suggest induction of gelatinase A and gelatinase B expression in collateral vessels compared with normal LAD tissue, when identical amounts of total protein were loaded onto each lane in the gel. Based on plasminogen-casein zymography, we observed the tissue plasminogen activator level to be increased in collateral vessels. On the basis of immunoblot and mRNA (Northern blot) analyses, we determined that the MMP-1 level was induced in collateral vessels 2 and 4 months after ameroid occlusion. In contrast with MMP-1, the level of TIMP-1 (tissue inhibitor of metelloproteinases) was decreased significantly (p < 0.001) in collateral compared with LAD vessels, suggesting a role for arterial TIMP in anti-angiogenic activity. Collectively, these results suggest that chronic occlusion of a major coronary artery induces upregulation of vascular remodeling mechanisms subserving collateral development. Increased MMP-2 activity in collaterals may be associated with decreased levels of tissue inhibitor of metalloproteinases and fibrous tissue remodeling following angiogenic and (or) adaptive responses of the myocardium to chronic ischemia.
No takes yet. Share an insight, caveat, or question.
Tyagi et al. (1996) studied Coronary occlusion and collateral vessel development (n=4). Surgical placement of an ameroid occluder around the proximal left circumflex artery vs. Unoccluded arterial segments of the left anterior descending (LAD) artery was evaluated on Extracellular matrix metalloproteinase (MMP) expression and activity in coronary collateral arteries (p=<0.001). Chronic coronary occlusion in a canine model induced upregulation of MMPs and decreased TIMP-1 levels in collateral vessels compared with normal LAD vessels.
Synapse has enriched 10 related papers. Consider them for comparative context: